SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing intense selling pressure as investors weigh significant AI infrastructure capital expenditures against concerns over rising debt and a credit rating downgrade. Community sentiment is deeply divided between retail participants who are aggressively buying the dip at 52-week lows and those warning that the company's heavy reliance on massive AI contracts poses a long-term liquidity risk.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is currently trending as investors debate whether the recent sell-off presents a generational buying opportunity or reflects a deeper issue within the hyped quantum sector. While many community members are frustrated by the downward price action and institutional selling, others are doubling down, citing strong government ties, potential CHIPS Act funding, and the unique commercial viability of their neutral-atom sensor technology as indicators for long-term growth.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin shares are experiencing extreme volatility, rallying sharply following analyst commentary on its AI advertising engine's growth, though the stock remains under pressure from lingering investor concerns over merchant adoption. The community is actively debating whether this is a sustainable breakout or a temporary squeeze, with many retail traders highlighting the stock's high-beta nature and its tendency to undergo rapid sentiment shifts.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing extreme volatility and intense community discussion following a sharp drawdown, with many traders debating whether this 3x leveraged ETF is a dangerous falling knife or a prime buying opportunity ahead of its upcoming stock split. Investors are closely monitoring the South Korean market's technical volatility and margin-related liquidation concerns while balancing long-term optimism for semiconductor and memory chip demand.

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.

Q32 Bio Inc.

Q32 Bio is experiencing significant volatility and high trading volume following the release of positive topline data from its Phase 2a alopecia areata clinical trial. The community remains deeply divided, with bulls pointing to the clinical success as a major catalyst for long-term growth while bears emphasize concerns over potential share dilution and current valuation.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is trending as investors digest a raised revenue guidance for the second quarter and progress on its strategic capital platform, while the community remains fiercely divided between long-term bulls highlighting a massive contracted project backlog and bears questioning transparency and historical share dilution. Despite a volatile trading environment, market participants are closely monitoring high short interest levels and the potential for a significant squeeze as the company works to convert multi-billion dollar contracts into recognized revenue.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is seeing intense community debate as investors weigh the company's aggressive acquisition strategy, including the DZYNE deal, against persistent concerns regarding share dilution and short interest. While bulls highlight the drone sector's potential and upcoming earnings as a pivotal turning point, bears remain focused on technical weakness and downward pressure on the stock price.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle is experiencing significant market volatility and trading near multi-year lows, driven by ongoing investor concerns regarding portion sizing, pricing power, and leadership execution. While some investors view the current valuation as a potential long-term entry point, the community remains deeply divided, with many actively debating whether the brands fundamentals are fundamentally broken or if this decline represents an oversold buying opportunity.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund is trending as investors react to escalating geopolitical tensions in the Strait of Hormuz, where military strikes and regional conflicts are fueling uncertainty regarding global crude supplies. The community is actively debating the impact of these developments on oil price volatility and the potential for a broader conflict to disrupt energy transit lanes.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is experiencing significant volatility and downward pressure as the market digests the dilution from the TopBuild acquisition and potential selling from former shareholders. Despite this immediate turbulence, the community remains divided between those bracing for further downside and long-term investors viewing the pullback as an accumulation opportunity based on the company's aggressive growth strategy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kura Oncology Reports Q1 2026 Results: Full Earnings Call Transcript

Kura Oncology (NASDAQ:KURA) released first-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below.
This content is powered by Benzinga APIs. For comprehensive financial dataread more...

Kura Oncology (KURA) Reports Q1 Loss, Tops Revenue Estimates

Kura Oncology (KURA) delivered earnings and revenue surprises of +5.33% and +21.30%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Celldex Therapeutics (CLDX) Reports Q1 Loss, Misses Revenue Estimates

Celldex (CLDX) delivered earnings and revenue surprises of -6.88% and -98.87%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Will MeiraGTx Holdings PLC (MGTX) Report Negative Q1 Earnings? What You Should Know

MeiraGTx (MGTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kura Oncology (KURA) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Kura Oncology (KURA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kura Oncology (KURA) Projected to Post Quarterly Earnings on Thursday

Kura Oncology (NASDAQ:KURA) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-kura-oncology-inc-stock...

Moody Aldrich Partners LLC Buys New Position in Kura Oncology, Inc. $KURA

Moody Aldrich Partners LLC bought a new stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 179,728 shares of the company's s...

KURA Stock Rallies 8% on Strong Preliminary Renal Cancer Study Data

Kura Oncology shares jump 8% as FIT-001 data show strong tumor response and disease control with darlifarnib combination in pretreated renal cancer patients.

Kura Oncology (KURA) Moves 8.3% Higher: Will This Strength Last?

Kura Oncology (KURA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Kura Oncology, Inc. (NASDAQ:KURA) Given Average Recommendation of "Moderate Buy" by Brokerages

Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) has received an average recommendation of "Moderate Buy" from the thirteen brokerages that are currently covering the stock, MarketBeat reports...

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Feed

News

Sentiment

Earnings

Fundamentals

Info

KURAKura Oncology Inc

Fundamentals

Latest KURA News